Hostname: page-component-7b7567c8c-8tzhz Total loading time: 0 Render date: 2026-11-19T07:44:07.966Z Has data issue: false hasContentIssue false

Use of Public Research and Manufacturing Enterprises to Lower Prescription Drug Prices and Increase Innovation

Published online by Cambridge University Press:  16 December 2024

Alex Moss
Affiliation:
PUBLIC INTEREST PATENT LAW INSTITUTE, LOS ANGELES, CALIFORNIA, USA
Dana Brown
Affiliation:
THE DEMOCRACY COLLABORATIVE, WASHINGTON, D.C., USA
S. Sean Tu
Affiliation:
WEST VIRGINIA UNIVERSITY COLLEGE OF LAW, MORGANTOWN, WEST VIRGINIA, USA
Rights & Permissions [Opens in a new window]

Abstract

This article proposes building on the success of publicly funded drug research and development and expanding the model to include the full cycle development, testing, manufacture and distribution of innovative and affordable new drugs.

Information

Type
Columns: Health Policy Portal
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of American Society of Law, Medicine & Ethics